A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
Status:
Recruiting
Trial end date:
2024-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness and safety of polatuzumab vedotin in
combination with R-miniCHP in patients 75 years and older with DLBCL.